Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Recruiting · NCT07746427 · Interventional (participants receive a specific treatment) · Lead sponsor: Weill Medical College of Cornell University
View the official record on ClinicalTrials.gov →Interventions studied
Digital App Mindfulness MeditationMindfulness Meditation Sheet
What this trial is about
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Who can take part
Age range
13 Years to 17 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adolescents age 13-17 years.
- Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors.
- Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.
Exclusion criteria
- Started on a biologic agent (i.e. dupxient) within the past 3 months.
- Mild atopic dermatitis via PO-SCORAD score on enrollment.
Where it is running
2 locations listed across 1 US state.
- Weill Cornell Medicine - New York, New York, United States
- Columbia University Irving Medical Center - New York, New York, United States